$CSL Cashflow Statement | Understand Stock

$CSL

$345.97 +$0.93 (0.27%) Close

$CSL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net income
Reconciliation of net income to cash flows provided by operating activities:
Depreciation
Amortization
Lease expense
Stock-based compensation
Loss on extinguishment of debt
Deferred taxes
(Gain) loss on sale of discontinued operations
Other operating activities, net
Changes in assets and liabilities, excluding effects of acquisitions:
Receivables
Inventories
Contract assets
Prepaid expenses and other assets
Accounts payable
Other current liabilities
Contract liabilities
Other long-term liabilities

Net cash provided by operating activities
Investing activities:
Proceeds from sale of discontinued operations, net of cash disposed
Capital expenditures
Acquisitions, net of cash acquired
Investment in securities
Other investing activities, net
Net cash provided by (used in) investing activities
Financing activities:
Proceeds from notes
Repayments of notes
Borrowings from revolving credit facility
Repayments of revolving credit facility
Repurchases of common stock
Dividends paid
Proceeds from exercise of stock options
Withholding tax paid related to stock-based compensation
Financing costs
Other financing activities, net
Net cash provided by (used in) financing activities
Effect of foreign currency exchange rate changes on cash and cash equivalents
Change in cash and cash equivalents
Less: change in cash and cash equivalents of discontinued operations
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Comments